November 5, 2014 / 5:13 PM / 3 years ago

BUZZ-Xenon Pharmaceuticals: Another strong IPO

1 Min Read

** Canadian clinical-stage biopharmaceutical company's shares up about 9 pct at $9.78, latest in a string of first-day pops as the U.S. IPO market powers on after last month's short-lived stumble.

** Shares touched high of $10.47, valuing company at $122.2 mln.

** Offering of 4m shares priced at $9, below $10-$12 marketed range.

** Company's pharmaceutical partners include Teva, Genentech, and Merck.

** Teva Pharmaceuticals purchased $10 mln worth of IPO shares; Genentech purchased about $4.5 mln of common stock in separate, concurrent private placement, at IPO price.

** Xenon intends to use proceeds, about $33.3 mln, to fund preclinical development of DS and XEN901 programs, and genetic research. (RM: lance.tupper.thomsonreuters.com@reuters.net)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below